Heart Failure Management

Classifying patients across heart failure stages

Heart failure is not a single event, it’s a progressive continuum that often begins silently and evolves over years.
While early detection is critical, ongoing management is what determines outcomes.
MyoStrain® enables clinicians to move from reactive to proactive guided therapy, providing quantitative insights to optimize care at every stage of disease progression.

Heart Failure Publications

February 5, 2023

Frontiers In Cardiovascular Medicine

Heart failure (HF) does not only reduce the life expectancy in patients, but their life is also often limited by HF symptoms leading to a reduced quality of life (QoL) and a diminished exercise capacity.

Read More

January 25, 2023

Frontiers in Cardiovascular Medicine

This article demonstrates MyoStrain’s ability to identify patients with subclinical LV dysfunction and those at risk for heart failure-related outcomes compared with LVEF, providing an additional diagnostic window for prevention treatments.

January 5, 2023

Frotiners In Cardiovascular Medicine

The main management strategy of heart failure with preserved ejection fraction (HFpEF) is prevention since HFpEF is associated with many cardiovascular (CV) risk factors, especially since HFpEF is linked to a high risk for both mortality and recurrent heart failure (HF) hospitalizations. Therefore, there is a need for new tools to identify patients with a high risk profile early. Regional strain assessment by CMR seems to be superior in describing deformation impairment in HF. The MyoHealth score is a promising tool to identify cardiac changes early.

Heart Failure Publications

January 5, 2023

Hashemi, D. et al.

  • This study found that the MyoHealth Score was able to detect differences in regional strain between healthy controls, asymptomatic patients with cardiovascular risk factors, and HFpEF patients — all of whom had similar and preserved LVEF — suggesting the tool can identify at-risk patients before symptoms develop.

March 1, 2022

Kazakauskaite, E. et al.

September 2023

Kazakauskaite, E. et al.